Article

Chemical surface modification of poly-ε-caprolactone improves Schwann cell proliferation for peripheral nerve repair

Materials Science Centre, Department of Engineering and Physical Sciences, The University of Manchester, Grosvenor Street, Manchester, M1 7HS, United Kingdom
Journal of Tissue Engineering and Regenerative Medicine (Impact Factor: 4.43). 02/2014; 8(2). DOI: 10.1002/term.1509
Source: PubMed

ABSTRACT Poly-ε-caprolactone (PCL) is a biodegradable and biocompatible polymer used in tissue engineering for various clinical applications. Schwann cells (SCs) play an important role in nerve regeneration and repair. SCs attach and proliferate on PCL films but cellular responses are weak due to the hydrophobicity and neutrality of PCL. In this study, PCL films were hydrolysed and aminolysed to modify the surface with different functional groups and improve hydrophilicity. Hydrolysed films showed a significant increase in hydrophilicity while maintaining surface topography. A significant decrease in mechanical properties was also observed in the case of aminolysis. In vitro tests with Schwann cells (SCs) were performed to assess film biocompatibility. A short-time experiment showed improved cell attachment on modified films, in particular when amino groups were present on the material surface. Cell proliferation significantly increased when both treatments were performed, indicating that surface treatments are necessary for SC response. It was also demonstrated that cell morphology was influenced by physico-chemical surface properties. PCL can be used to make artificial conduits and chemical modification of the inner lumen improves biocompatibility Copyright © 2012 John Wiley & Sons, Ltd.

3 Followers
 · 
102 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The ester-containing polymers, in particular polyesters, are widely used as biomedical materials due to their industrial availability and, in many cases, degradability. However, the commercially available polyesters are usually absent of bioactive sites or motifs to meet the requirements of some specific biomedical uses, especially in the field of tissue engineering and regenerative medicine. Aminolysis is a convenient and versatile method to introduce –NH2 or other functional groups onto the polyester surface. Functional moieties can then be conjugated to or grafted from these active sites. Numerous studies have managed to fabricate a series of functional surfaces on various types and forms of polyesters. They are capable of improving cell adhesion, proliferation and cellular functions, domination of stem cell differentiation and isolation of certain subgroup of cells, demonstrating the versatility of the aminolysis-based polyester surface modification in biomedical applications. The mechanism and kinetics of aminolysis reaction, as well as its subsequent influence on materials properties are discussed in this review. The successive functionalization strategies and derivative applications of the aminolyzed surfaces are introduced. Finally, the review concludes with current challenges and future perspectives.
    RSC Advances 01/2013; 3(8):2509-2519. DOI:10.1039/C2RA22358A · 3.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The gold standard in surgical management of a peripheral nerve gap is currently autologous nerve grafting. This confers patient morbidity and increases surgical time therefore innovative experimental strategies towards engineering a synthetic nerve conduit are welcome. We have developed a novel synthetic conduit made of poly ɛ-caprolactone (PCL) that has demonstrated promising peripheral nerve regeneration in short-term studies. This material has been engineered to permit translation into clinical practice and here we demonstrate that histological outcomes in a long-term in vivo experiment are comparable with that of autologous nerve grafting. A 1cm nerve gap in a rat sciatic nerve injury model was repaired with a PCL nerve conduit or an autologous nerve graft. At 18 weeks post surgical repair, there was a similar volume of regenerating axons within the nerve autograft and PCL conduit repair groups, and similar numbers of myelinated axons in the distal stump of both groups. Furthermore, there was evidence of comparable re-innervation of end organ muscle and skin with the only significant difference the lower wet weight of the muscle from the PCL conduit nerve repair group. This study stimulates further work on the potential use of this synthetic biodegradable PCL nerve conduit in a clinical setting.
    Neuroscience Letters 04/2013; 544. DOI:10.1016/j.neulet.2013.04.001 · 2.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies have explored many approaches to prevent and treat hypertrophic scars. However, most of them inhibit hypertrophic scars after their formation, without taking into account repairing tissue damage in the early stage and inhibiting scar hyperplasia in the late stage through combining treatments. In this study, Ginsenoside Rg3 (Rg3) loaded poly(D,L-lactide-co-glycolide) (PLGA) electrospun fibrous scaffolds were prepared by a co-solvent electrospinning method, and then hyaluronic acid (HA) was coated on the surface of the drug-loaded electrospun fibers by a pressure-driven permeation (PDP) wrapped method. The hydrophilic Rg3/PLGA/HA electrospun fibrous scaffolds showed the effect of combining treatments of promoting wound healing in the early stage and inhibiting scar hyperplasia in the late stage. The improved hydrophilicity together with a proper porous structure, a stable fibrous structure, durable mechanical properties and a similar drug release model suggested that the Rg3/PLGA electrospun scaffold coated with HA via PDP has great potential for drug-loaded tissue engineering scaffolds. The in vivo animal results showed that the Rg3/PLGA/HA could promote wound healing earlier and significantly inhibit scar hyperplasia compared to other control groups from macroscopic, histologic evaluation, and expression of collagen type I. The Rg3/PLGA/HA electrospun fibrous scaffolds open a new combined therapeutic approach for inhibiting hypertrophic scars.
    08/2013; 1(35). DOI:10.1039/C3TB20441C
Show more